Rhumbline Advisers Has $289,000 Stake in Ardent Health Partners, LLC (NYSE:ARDT)

Rhumbline Advisers increased its stake in Ardent Health Partners, LLC (NYSE:ARDT) by 23.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,913 shares of the company’s stock after purchasing an additional 3,266 shares during the period. Rhumbline Advisers’ holdings in Ardent Health Partners were worth $289,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC lifted its holdings in shares of Ardent Health Partners by 9.2% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 779,601 shares of the company’s stock valued at $13,136,000 after purchasing an additional 65,833 shares in the last quarter. R Squared Ltd acquired a new stake in Ardent Health Partners in the 4th quarter valued at approximately $37,000. Oliver Luxxe Assets LLC bought a new stake in Ardent Health Partners in the 4th quarter valued at approximately $1,465,000. JPMorgan Chase & Co. acquired a new position in Ardent Health Partners during the 3rd quarter worth approximately $154,000. Finally, Franklin Resources Inc. bought a new position in shares of Ardent Health Partners during the 3rd quarter worth approximately $15,839,000.

Ardent Health Partners Stock Performance

NYSE:ARDT opened at $14.58 on Monday. Ardent Health Partners, LLC has a 12-month low of $13.55 and a 12-month high of $20.72. The stock’s 50 day moving average price is $15.07 and its two-hundred day moving average price is $16.76. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.

Ardent Health Partners (NYSE:ARDT) last posted its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. On average, equities research analysts predict that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Analyst Upgrades and Downgrades

ARDT has been the topic of a number of research reports. Leerink Partners boosted their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Truist Financial cut their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Stephens restated an “overweight” rating and set a $22.00 price objective on shares of Ardent Health Partners in a research note on Thursday, February 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada reduced their price target on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Tuesday, March 4th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $21.18.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.